Pro Medicus Ltd (ASX: PME) shares have dropped more than 20% since their peak a few weeks ago. Is this an opportunity to buy?

Earnings per share were 1.21 euros, down 2 percent from 1.23 euros a year ago. Operating result or EBIT, however, grew 4 percent from last year to 126 million euros, and EBITDA climbed 25 percent ...

EQS-News: Nabaltec AG / Key word (s): Preliminary Results Nabaltec AG achieves slight revenue growth and an EBIT margin of 10.8% in 2024 according to preliminary figures 11.03.2025 / 10:00 CET/CEST ...

The cannabis industry, once fueled by sky-high revenue projections and aggressive expansion strategies, is undergoing a ...

TPI Cap reported robust financial performance for Q4 2024, with earnings per share (EPS ... the company’s strategic initiatives and strong EBIT growth have positioned it well for future success.

After a tough year in 2024, 2025 could bring significant upside for this S&P/ASX 200 Index (ASX: XJO) stock. Here’s what you ...

Roblon’s revenue and earnings for the first quarter of 2024/25 were in line with expectations The Board of Directors of Roblon A/S has today considered and approved the interim report for the first ...

On February 3, 2025, Dovre Group updated its guidance for 2024 as: Dovre Group's revenue is expected to be approximately 99 MEUR and the operating profit (EBIT) is expected to be approximately -12 ...

L'Air Liquide reported solid H2 results and announced a double-digit dividend per share increase. Click here to read an ...

J&T Global Express Limited (J&T Express), a leading global logistics provider, has announced its first-ever full-year profit ...

TP ICAP launched a share buyback program after profit rose, and said its plan to list Parameta Solutions in the U.S. is progressing.

The performance of Glencore’s share price has been lacklustre, to say the least. But could all that change over the next 12 ...